LMC | Manna Research is looking for individuals who have had a heart attack within the past year or heart failure within the past two years to participate in a clinical research trial. This research trial will be looking at an investigational high dose flu vaccine to see if it may help reduce the risk […]
LMC | Manna Research is looking for individuals who have Type 2 Diabetes to participate in a clinical research trial. This study will be exploring the safety of an investigational medication in lowering blood sugar levels for people living with Type 2 Diabetes who have mild to moderate kidney damage. Study related medication, supplies, and […]
Looking for new options for your Type 2 Diabetes? LMC | Manna Research is looking for individuals who have Type 2 Diabetes and who are currently taking insulin to participate in a clinical research trial. This research trial will be looking at a new generation of mealtime insulin to see if it can provide improved […]
Looking to help combat blood sugar lows? LMC | Manna Research is looking for individuals who have Type 2 Diabetes and who have experienced episodes of hypoglycemia (low blood sugar) to participate in a clinical research trial. This research trial will be looking at incorporating a longer acting insulin to possibly assist in reducing blood […]
Do you have Type 2 Diabetes? LMC | Manna Research is looking for individuals who have Type 2 Diabetes and uncontrolled blood sugar levels to participate in a clinical research trial. This research trial will be investigating an experimental diabetes medication to see if it may help reduce blood sugar levels as well as overall […]
Notice: JavaScript is required for this content.
Notice: JavaScript is required for this content.
Currently treating your Type 2 Diabetes with metformin? You may be eligible to participate in a research study about Type 2 Diabetes. Study medication, supplies, and other expenses will be provided. Speak with one of our diabetes specialist today at: 1-844-266-2662 Learn more at improvinghealth.ca Notice: JavaScript is required for this content.